This inventor holds 1 USPTO granted patent. Top assignee: Studiengesellschaft Kohle Mbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Christophe Aïssa
Introduction
Christophe Aïssa is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of chemistry, particularly in the development of chemotherapeutic agents. His work focuses on innovative compounds that have the potential to treat cancer effectively.
Latest Patents
Christophe Aïssa holds a patent for Iejimalid analogs and their uses. The invention relates to Iejimalides characterized by a specific formula, where various bonds can be present. These compounds are designed to serve as chemotherapeutic agents, showcasing their potential in cancer treatment.
Career Highlights
Aïssa is associated with Studiengesellschaft Kohle Mbh, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer therapies, reflecting his commitment to innovation in the pharmaceutical field.
Collaborations
Christophe Aïssa has collaborated with esteemed colleagues such as Alois Fürstner and Christina Nevado-Blàzquez. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.
Conclusion
Christophe Aïssa's contributions to the field of chemistry and his innovative patent for Iejimalid analogs underscore his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile